Tag: inflammatory

BOOKS TITLE: THE INFLAMMATORY RESET

BOOKS BOOKS HS CODE# 4901.99.00 TKC1 TITLE THE INFLAMMATORY RESET 27PLTS=1454CTNS(17448 CPS) . TXGU7473596 001 THIS CONSIGNMENT CONTAINS HEAT TREATED WOODEN PALLETS WHICH ARE COMPLIED THIS STANDARD OF ISPM 15.

37 PALLETS 2335 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0437740 001 TREATMENT OR PREVENTION OF HYPOKALEMIA RUFINAMIDE TAB 400MG 120 NDC CODE:6846207140 8 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER M EDICATIONS TO PREVENT OR CONT ROL SEIZURES (EPILEPSY) ASSO CIATED WITH LENNOX-GASTAUT S MNBU0437740 001 YNDROME (LGS SAXAGLIPTIN TA B 5MG 30 NDC CODE:68462072730 FDA PRODUCT CODE NO.:61 P C A 99 H. T. S NO.: 3004.90.9 220 ANDA NO.:205994 THERAPEU TICE USE: :#ANTI-DIABETIC AGE NT INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA MNBU0437740 001 PRODUCT CODE: 62 GCE42 H. T . S NO.:3004.90.92.40 ANDA N O.203501 THERAPEUTIC USE: IN DOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT ST IFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITI S. IT IS ALSO USED TO RELIEVE MNBU0437740 001 PAIN FROM VARIOUS OTHER CON DITIONS. THIS MEDICATION IS K NOWN AS A NONSTEROIDAL ANTI- INFLAMMATORY DRUG (NSAID). .. . THIS EFFECT HELPS TO DECRE ASE SWELLING AND PAIN. FEN OFIBRATE CAP 200MG 100 NDC CO DE:68462058201 FDA PRODUCT CO MNBU0437740 001 DE NO.: 61 JCE 09 H. T. S NO .: 3004.90.92.20 ANDA NO.: 2 05566 THERAPEUTICE USE: - IN DICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO MNBU0437740 001 LEMIA OR MIXED DYSLIPIDEMIA FENOFIBRATE CAP 134MG 100 N DC CODE:68462058101 FDA PRODU CT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA N O.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE TH ERAPY TO DIET FOR THE REDUCTI MNBU0437740 001 ON OF LDL-C, TOTAL-C, TRIGLYC ERIDES AND APO B IN DULT PAT IENTS WITH PRMARY HYPERCHOLE STEROLEMIA OR MIXED DYSLIPIDE MIA NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 MNBU0437740 001 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC TACROLIMUS OINT 0. 1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS MNBU0437740 001 A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO MNBU0437740 001 .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:6846206850 1 FDA PRODUCT CODE NO.: 64 T MNBU0437740 001 C E 08 H. T. S NO.:3004.90. 92.15 ANDA NO.: 206662 THERA PEUTICE USE: :#TO PREVENT REJ ECTION OF A KIDNEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO MNBU0437740 001 DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001748 DT. 30.12.2023 F22487001749 DT. 30.12.2023 S /BILL NO: 4020294 DT:30/12/202 MNBU0437740 001 3 S/BILL NO: 4020292 DT:30/12 /2023 NET WT. 3110.165 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

27 PALLETS 1304 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.02MG 84 N DC CODE:68462072029 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE MNBU0385776 001 : - ORAL CONTRACEPTIVE NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC CO MMERCIAL & CUSTOM INVOICE NO. MNBU0385776 001 F22452001936 DT. 23.07.2023 F22452001934 DT. 23.07.2023 S /BILL NO: 2661393 DT 23-JUL-20 23 S/BILL NO: 2661392 DT 23-J UL-2023 NET WT. 3275.31 KGS 01 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 DE MNBU0385776 001 GREES TO +25 DEGREES NOTIFY P ARTY:2 SHOROUQ COMMODITIES TR ADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR.

37 PALLETS 1955 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 100 NDC CODE: 68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0656142 001 INFLAMMATORY, ANALGESIC PR AVASTATIN SOD TAB 40MG 500 ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC PRAVASTATI N SOD TAB 40MG 500 NDC CODE:6 MNBU0656142 001 8462019705 FDA PRODUCT CODE N O.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77- 987 THERAPEUTICE USE: -HYPOL IPDAEMIC PRAVASTATIN SOD TA B 40MG 90 NDC CODE:6846201979 0 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90 MNBU0656142 001 .92.20 ANDA NO.: 77-987 THER APEUTICE USE: -HYPOLIPDAEMIC CICLOPIROX OLAMINE CREAM 0. 77% 90GM NDC CODE:68462029792 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40. 49.50 ANDA NO.:- 90 - 273 TH ERAPEUTICE USE:-ANTIFUNGAL US MNBU0656142 001 E. NORETHINDRONE ACE TAB 5M G 50 NDC CODE:68462030450 FD A PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTIC E USE:- SECONDARY AMENORRHEA ,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING LEVONORGE MNBU0656142 001 STREL/EE TAB 0.09/0.02MG 84 N DC CODE:68462063729 FDA PRODU CT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PRE GNANCY OXCARBAZEPINE TAB 30 0MG 100 NDC CODE:68462013801 MNBU0656142 001 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAP EUTICE USE:-ANTI CONVULSANT A GENT 02 DATA LOGGERS COM MERCIAL & CUSTOM INVOICE NO. F22452001733 DT. 08.07.2023 F 22452001734 DT. 08.07.2023 F2 MNBU0656142 001 2452001735 DT. 08.07.2023 F22 452001736 DT. 08.07.2023 F224 52001737 DT. 08.07.2023 F2245 2001755 DT. 10.07.2023 S/BILL NO:2346309 DT.10.07.2023 S/B ILL NO:2346285 DT.10.07.2023 S/BILL NO:2346276 DT.10.07.20 23 S/BILL NO:2346877 DT.10.07 MNBU0656142 001 .2023 S/BILL NO:2346282 DT.10 .07.2023 S/BILL:NO:2346308 DT .10.07.2023 NET WT:7863.65KGS NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM MNBU0656142 001 IR.

23 PALLETS 1120 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0489425 001 INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - -TREA TMENT OF TREAT GASTROESOPHAGE AL REFLUX DISEASE VERAPAMI MNBU0489425 001 L HCL ER TAB 240MG 100 NDC CO DE:68462026001 FDA PRODUCT CO DE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -78-906 THERAPEUTICE USE:-AN GINA 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. MNBU0489425 001 F22452001350 DT. 17.06.2023 F22452001352 DT. 17.06.2023 F 22452001375 DT. 18.06.2023 S/ BILL NO:1849547 DT 19-JUN-2023 S/BILL NO:1849554 DT. 19-JUN -2023 S/BILL NO:1862758 DT 19 -JUN-2023 NOTIFY PARTY:2 SHO ROUQ COMMODITIES TRADING DMCC MNBU0489425 001 UNIT NO. 98, DMCC BUSINESS CE NTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT D.ARAB EMIR.

37 PALLETS 2795 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 250MG 500 NDC CODE: 68462018805 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0564920 001 INFLAMMATORY, ANALGESIC NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T OPIRAMATE TAB 25MG 500 NDC CO MNBU0564920 001 DE:68462010805 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 077627 THERAPEUTICE USE: ANT ICONVULSANT FLUCONAZOLE TAB 200MG 30 NDC CODE:6846201043 0 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90 MNBU0564920 001 .92.45 ANDA NO.:-77 - 253 TH ERAPEUTICE USE:-ANTIFUNGAL TOPIRAMATE TAB 25MG 60 NDC C ODE:68462010860 FDA PRODUCT C ODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT ACAMPROSATE MNBU0564920 001 CALCIUM DR TAB 333MG 180 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO .:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDE NCE NORETHINDRONE ACE TAB 5 MG 50 NDC CODE:68462030450 F MNBU0564920 001 DA PRODUCT CODE NO.65 J C A 2 5 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTI CE USE:- SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING 03 DATA LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEM MNBU0564920 001 PERATURE RANGE : +15 DEGREES T O +25 DEGREES NET WT:7788. 78 KGS INV NO:F22452000580 DT. 05.05.2023 INV NO:F224520 00581 DT. 05.05.2023 INVV NO: F22452000583 DT. 05.05.2023 I NV NO:F22452000584 DT. 06.05.2 023 INV NO:F22452000589 DT. 0 MNBU0564920 001 6.05.2023 S/BILL NO:9820215 DT:06.05.2023 S/BILL NO:9822 397 DT:06.05.2023 S/BILL NO:9 822602 DT:06.05.2023 S/BILL N O:9828365 DT:06.05.2023 S/BIL L NO:9820216 DT:06.05.2023 NOTIFY PARTY:2 SHOROUQ COM MODITIES TRADING DMCC UNIT MNBU0564920 001 NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR.

24 PALLETS 1779 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0549360 001 INFLAMMATORY, ANALGESIC CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST FLUCONAZOLE TAB 200MG 30 MNBU0549360 001 NDC CODE:68462010430 FDA PR ODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 A NDA NO.:-77 - 253 THERAPEUTIC E USE:-ANTIFUNGAL OMEPRAZO LE DR CAP 20MG 1000 NDC CODE: 68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 MNBU0549360 001 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE TOPIRAMATE T AB 25MG 60 NDC CODE:684620108 60 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:- 77-627 TH MNBU0549360 001 ERAPEUTICE USE:-ANTICONVULSAN T 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4561.78 KGS INV NO :F22452000594 DT. 06.05.2023 INV NO:F22452000595 DT. 06.05. 2023 INV NO:F22452000597 DT. 06.05.2023 S/BILL NO:9855046 MNBU0549360 001 DT:08.05.2023 S/BILL NO:98550 33 DT:08.05.2023 S/BILL NO:98 55036 DT:08.05.2023 NOTIFY PARTY:2 SHOROUQ COMMODITIE S TRADING DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT MNBU0549360 001 D.ARAB EMIR.

PART OF 1X40'GP CONTAINER STC=- PRINTED BOO KS 6 PLTS ANTI INFLAMMATORY KITCHEN COOKBO OK PO 00094479 HS CODE 4901990070 ISBN 9781 454931386 4 PLTS DARE TO QUESTION PO 00094 451 HS CODE 4901990070 ISBN 9781454934578 .

42 PALLETS 2281 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 5 00 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 MNBU0548786 001 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC FELODIPINE ER TAB 2.5MG 1 00 NDC CODE:68462023301 FDA PRODUCT CODE NO.: 62OCB 32 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 90-365 T HERAPEUTICE USE: - TREATMEN MNBU0548786 001 T OF HYPERTENSION G ABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AGENT TELMISARTAN TA MNBU0548786 001 B 80MG 30 NDC CODE:68462020 130 HTS NO : 3004.90.92.20 FDA CODE : 62 O C A 09 A NDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NORETHINDRONE TAB 0.35MG MNBU0548786 001 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. TEL MISARTAN TAB 80MG 30 NDC CO DE:68462020130 HTS NO : 300 MNBU0548786 001 4.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 T HERAPEUTICE USE : INDICATED FOR THE TREATMENT OF HY PERTENSION, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F2235200 5968 DT. 18.03.2023 F223520 MNBU0548786 001 05969 DT. 18.03.2023 F22352 005970 DT. 18.03.2023 F2235 2005972 DT. 18.03.2023 F223 52005977 DT. 18.03.2023 S/B ILL NO: 8583088 DT 18-MAR-2023 S/BILL NO: 8583079 DT 18-M AR-2023 S/BILL NO: 8583082 DT 18-MAR-2023 S/BILL NO: 8 MNBU0548786 001 583087 DT 18-MAR-2023 S/BIL L NO: 8586589 DT 18-MAR-2023 NET WT. 8321.52 KGS 02 DA TA LOGGERS SET TEMPERAT URE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - MNBU0548786 001 07430 USA

14 PALLETS 626 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 6.25MG 100 NDC CODE:68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-25 SUDU8191854 001 1 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONI ST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI- SUDU8191854 001 INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOI CE NO. F22352005843 DT. 10. 03.2023 S/BILL NO: 8404630 DT 11-MAR-2023 NET WT.3509. 11 01 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANG SUDU8191854 001 E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

8 PALLETS 570 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 250MG 100 NDC CODE:6 8462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I MNBU0419285 001 NFLAMMATORY, ANALGESIC NAP ROXEN TAB 250MG 500 NDC CODE: 68462018805 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OL MESARTAN MEDOX TAB 5MG 90 NDC MNBU0419285 001 CODE:68462043690 FDA PRODUCT CODE NO.:62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: :#TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE COMMERCIAL & CUSTOM MNBU0419285 001 INVOICE NO. F22352004943 DT. 21.01.2023 F22352004942 DT. 2 1.01.2023 S/BILL NO: 7189624 DT 23-JAN-2023 S/BILL NO:7202 306 DT 23-JAN-2023 NET WT. 13 69.24 KGS 01 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE MNBU0419285 001 DRIVE, NEW JERSEY MAHWAH - 07430 USA

17 PALLETS 804 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0204348 001 INFLAMMATORY, ANALGESIC NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O XCARBAZEPINE TAB 300MG 100 ND MNBU0204348 001 C CODE:68462013801 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT COM MERCIAL & CUSTOM INVOICE NO. F22352004354 DT. 22.12.2022 F 22352004366 DT. 22.12.2022 F2 MNBU0204348 001 2352004367 DT. 23.12.2022 S/B ILL NO: 6383961 DT 23-DEC-2022 S/BILL NO: 6398030 DT 23-DEC -2022 S/BILL NO: 6398017 DT 2 3-DEC-2022 NET WT.4555.443 KG S 00 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 SHOROUQ COMMODITIES MNBU0204348 001 TRADING DMCC UNIT NO. 98, DM CC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DU BAI DUBAI UTD.ARAB EMIR.

34 PALLETS 2822 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I MNBU0542181 001 NFLAMMATORY, ANALGESIC NAP ROXEN TAB 375MG 100 NDC CODE: 68462018901 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC NA PROXEN TAB 375MG 500 NDC CODE MNBU0542181 001 :68462018905 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T OPIRAMATE TAB 50MG 500 NDC CO DE:68462015305 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S MNBU0542181 001 NO.: 3004.49.00.20 ANDA NO.: 077627 THERAPEUTICE USE: ANT ICONVULSANT CARVEDILOL TAB 6.25MG 500 NDC CODE:684620163 05 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO MNBU0542181 001 ACEPTOR ANTAGONIST CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST ROSUVASTATIN TAB 5MG 90 NDC MNBU0542181 001 CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E ROSUVASTATIN TAB 20MG 90 MNBU0542181 001 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D ISEASE ROSUVASTATIN TAB 20M MNBU0542181 001 G 1000 NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 79172 THERAPEU TICE USE: TO TREAT HIGH CHOLE STEROL AND RELATED CONDITIONS , AND TO PREVENT CARDIOVASCUL AR DISEASE ROSUVASTATIN TA MNBU0542181 001 B 20MG 1000 NDC CODE:68462026 310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 79172 THE RAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTAT MNBU0542181 001 IN TAB 5MG 1000 NDC CODE:6846 2026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE. CALCI MNBU0542181 001 POTRIENE CREAM 0.005% 60GM (GS ) NDC CODE:51407060560 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: TOPICAL ANTI-PSORIATIC COMMERCIAL & CUSTOM INVOICE NO. F22352004079 DT. 02.12.2 MNBU0542181 001 022 F22352004080 DT. 02.12.20 22 F22352004050 DT. 30.11.202 2 F22352004082 DT. 02.12.2022 F22352004092 DT. 03.12.2022 F22352004052 DT. 30.11.2022 F22352004029 DT. 30.11.2022 S /BILL NO: 5937375 DT:05/12/202 2 S/BILL NO: 5933578 DT:05/12 MNBU0542181 001 /2022 S/BILL NO: 5932230 DT:0 5/12/2022 S/BILL NO: 5932167 DT:05/12/2022 S/BILL NO: 5936 093 DT:05/12/2022 S/BILL NO: 5933587 DT:05/12/2022 S/BILL NO: 5859138 DT:01/12/2022 NET WT. 7087.103 KGS 24 DATA LOG GERS SET TEMPERATURE : +18 MNBU0542181 001 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND

17 PALLETS 945 CARTONS PHARMACEUTICALS AS UNDER OXCARBAZEPINE TAB 300MG 100 N DC CODE:68462013801 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE MNBU0474791 001 :-ANTI CONVULSANT AGENT RO PINIROLE TAB 4MG 100 NDC CODE :68462025801 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM NAP ROXEN TAB 500MG 500 NDC CODE: MNBU0474791 001 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S MNBU0474791 001 NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT COMMERC IAL & CUSTOM INVOICE NO. F223 52003841 DT. 21.11.2022 F2235 2003896 DT. 24.11.2022 F22352 003897 DT. 24.11.2022 NET WT. 4,705.40 KGS 02 DATA LOGGE MNBU0474791 001 RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 5642798 DT 22-NOV- 2022 S/BILL NO: 5718502 DT 25-NOV-2022 S/BILL NO: 5718 MNBU0474791 001 496 DT 25-NOV-2022

3 PALLETS 105 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0379876 001 INFLAMMATORY, ANALGESIC CO MMERCIAL & CUSTOM INVOICE NO. F22352003301 DT. 21.10.2022 S/BILL NO: 5026925 DT:22-OCT-2 2 NET WT: 806.19 KGS 01 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN MNBU0379876 001 C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

23 PALLETS 1084 CARTONS P HARMACEUTICALS AS UNDER CLO BETASOL PROP OINT 0.05% 60GM NDC CODE:68462053065 FDA PROD UCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 208933 THERAPEUTICE US MNBU3469994 001 E: - INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRU RITIC MANIFESTATIONS OF CORTI COSTEROID-RESPONSIVE DERMATOE SE CLOBETASOL PROP OINT 0.0 5% 60GM NDC CODE:68462053065 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.9 MNBU3469994 001 2.45 ANDA NO.: 208933 THERAP EUTICE USE: - INDICATED FOR T HE RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOESE CLOBETASOL PROP CREAM 0.05% 60GM NDC CODE:68 462052965 FDA PRODUCT CODE NO MNBU3469994 001 .: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2090 95 THERAPEUTICE USE: - CLOBE TASOL PROPIONATE CREAM IS A S UPER-HIGH POTENCY CORTICOSTER OID FORMULATIONS INDICATED FO R THE RELIEF OF THE INFLAMMA TORY AND PRURITIC MANIFESTATI MNBU3469994 001 ONS OF CORTICOSTEROID-RESPONS IVE DERMATOSES CLOBETASOL PROP CREAM 0.05% 30GM NDC COD E:68462052935 FDA PRODUCT COD E NO.: 64 L C J 67 H. T. S N O.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE: - C LOBETASOL PROPIONATE CREAM MNBU3469994 001 IS A SUPER-HIGH POTENCY CORTI COSTEROID FORMULATIONS INDICA TED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOSES ATOVA QUONE OS 750MG/5ML 210ML NDC CODE:68462042121 FDA PRODUCT MNBU3469994 001 CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO .: 209685 USED TO PREVENT OR TREAT A SERIOUS LUNG INFECTIO N CALLED PNEUMOCYSTIS PNEUMO NIA (PCP). THIS MEDICATION HE LPS TO STOP INFECTION SYMPTOM S SUCH AS FEVER, COUGH, TIRE MNBU3469994 001 DNESS, AND SHORTNESS OF BREAT H. COMMERCIAL & CUSTOM INVO ICE NO. F22335003166 DT. 13.1 0.2022 F22335003167 DT. 13.10 .2022 F22335003204 DT. 15.10. 2022 F22335003205 DT. 15.10.2 022 F22335003206 DT. 15.10.20 22 S/BILL NO: 4802762 DT: 13/ MNBU3469994 001 10/2022 S/BILL NO: 4803290 DT : 13/10/2022 S/BILL NO: 48653 11 DT: 17/10/2022 S/BILL NO: 4864843 DT: 17/10/2022 S/BILL NO: 4864831 DT: 17/10/2022 N ET WT. 3591.864 KGS 23 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER MNBU3469994 001 ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAN D

21 PALLETS 612 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP SOLN 0.05% 50ML ND C CODE:68462053253 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: MNBU3469994 001 - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) MO METASONE FURO CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN MNBU3469994 001 DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:684620385 02 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:090506 THER APEUTICE USE: MOMETASONE FURO MNBU3469994 001 ATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICAT ED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOSES IN PATIEN TS #12 YEARS OF AGE. MOME TASONE FURO SOLN 0.1% 60ML ND MNBU3469994 001 C CODE:68462038502 FDA PRODUC T CODE NO.: 62 F C L 53 H. T . S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL S OLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN MNBU3469994 001 D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 MNBU3469994 001 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. MNBU3469994 001 COMMERCIAL & CUSTOM INVOICE NO . F22335003142 DT. 12.10.2022 F22335003168 DT. 13.10.2022 F22335003207 DT. 15.10.2022 S/BILL NO: 4778492 DT: 12/10/ 2022 S/BILL NO: 4803493 DT:1 3/10/2022 S/BILL NO: 4867760 DT:17/10/2022 NET WT. 2,228. MNBU3469994 001 64 KGS 21 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +1 8 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA

26 PALLETS 662 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP SOLN 0.05% 25ML N DC CODE:68462053228 FDA PRODU CT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE MNBU3471435 001 : - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONST ERILE LIQUID / CLOBETASOL PRO PIONATE (GLUCOCORTICOID) T RIAMCINOLONE ACE OINT 0.5% 15G M NDC CODE:68462079817 FDA P RODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 A MNBU3471435 001 NDA NO.:206379 THERAPEUTICE U SE: - REDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN MOMETASONE FURO SOLN 0.1% 6 0ML NDC CODE:68462038502 FDA PRODUCT CODE NO.: 62 F C L 5 3 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTIC MNBU3471435 001 E USE: MOMETASONE FUROATE TO PICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOSES IN PATIENTS #12 YEARS OF AGE. MOMETASONE MNBU3471435 001 FURO SOLN 0.1% 30ML NDC CODE: 68462038537 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO. : 3004.90.92.45 ANDA NO.:090 506 THERAPEUTICE USE: MOMETA SONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROI D INDICATED FOR THE RELIEF OF MNBU3471435 001 THE INFLAMMATORY AND PRURITI C MANIFESTATIONS OF CORTICOS TEROID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE . MOMETASONE FURO OINT 0.1% 45GM NDC CODE:68462022555 F DA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49. MNBU3471435 001 50 ANDA NO.:78-571 THERAPEUT ICE USE: ANTI-INFLAMMATORY- DERMATOLOGIC COMMERCIAL & C USTOM INVOICE NO. F2233500286 5 DT. 28.09.2022 F22335002878 DT. 29.09.2022 S/BILL NO: 4 520878 DT:29/09/2022 S/BILL N O: 4547428 DT:30/09/2022 NET MNBU3471435 001 WT.2287.68 26 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

11 PALLETS 265 CARTONS PHARMACEUTICALS AS UNDER C LOBETASOL PROP OINT 0.05% 60GM NDC CODE:68462053065 FDA PR ODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 A NDA NO.: 208933 THERAPEUTICE MNBU3471435 001 USE: - INDICATED FOR THE RELI EF OF THE INFLAMMATORY AND P RURITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMAT OESE CLOBETASOL PROP OINT 0 .05% 45GM NDC CODE:6846205304 7 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90 MNBU3471435 001 .92.45 ANDA NO.: 208933 THER APEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOESE COMMERCIAL & CUSTOM INVOICE NO. F223350028 79 DT. 29.09.2022 F2233500299 MNBU3471435 001 1 DT. 30.09.2022 S/BILL NO: 4551100 DT:30/09/2022 S/BILL NO: 4642221 DT:06/10/2022 NE T WT. 912.96 11 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK MNBU3471435 001 SPECIALTY S.A. SWITZERLAND ( GSSA) PLACE NUMA-DROZ 2 NEUC HATEL - 2000 SWITZERLAND

36 PALLETS 2229 CARTONS PHARMACEUTICALS AS UNDER TO PIRAMATE TAB 50MG 500 NDC COD E:68462015305 FDA PRODUCT COD E NO.: 61 M C A 40 H. T. S N O.: 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: ANTI MNBU0571955 001 CONVULSANT TOPIRAMATE TAB 2 00MG 60 NDC CODE:68462011060 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT ATOMOXETINE CAP 60MG 30 NDC CODE:68462026930 FDA PRODUCT MNBU0571955 001 CODE NO.: 79019 H. T. S NO. : 3004.90.92.90 ANDA NO.: 07 9019 THERAPEUTICE USE: - TRE ATMENT OF ATTENTION - DEFICIT /HYPERACIVITY DISORDER ROP INIROLE TAB 3MG 100 NDC CODE: 68462025701 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. MNBU0571955 001 : 3004.90.92.40 ANDA NO.:- 9 0-135 THERAPEUTICE USE:-TREA TMENT OF PARKINSONISM FELO DIPINE ER TAB 2.5MG 100 NDC C ODE:68462023301 FDA PRODUCT C ODE NO.: 62OCB32 H. T. S NO. : 3004.90.92.20 ANDA NO.: 90 -365 THERAPEUTICE USE: - TRE MNBU0571955 001 ATMENT OF HYPERTENSION NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC RO PINIROLE TAB 3MG 100 NDC CODE MNBU0571955 001 :68462025701 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM COM MERCIAL & CUSTOM INVOICE NO. F22352002827 DT. 27.09.2022 F 22352002836 DT. 28.09.2022 F2 MNBU0571955 001 2352002869 DT. 29.09.2022 F22 352002885 DT. 29.09.2022 NET WT. 8,461.76 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP MNBU0571955 001 ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA

32 PALLETS 2847 CARTONS PH ARMACEUTICALS AS UNDER ATOM OXETINE CAP 60MG 30 NDC CODE: 68462026930 FDA PRODUCT CODE NO.: 79019 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE: - TREATMENT MNBU0425312 001 OF ATTENTION - DEFICIT/HYPER ACIVITY DISORDER (ADHD NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC RO MNBU0425312 001 PINIROLE TAB 0.5MG 100 NDC CO DE:68462025401 FDA PRODUCT CO DE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.: - 90-135 THERAPEUTICE USE:-T REATMENT OF PARKINSONISM R OPINIROLE TAB 2MG 100 NDC COD E:68462025601 FDA PRODUCT COD MNBU0425312 001 E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM AT OMOXETINE CAP 60MG 30 NDC COD E:68462026930 FDA PRODUCT COD E NO.: 79019 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 MNBU0425312 001 THERAPEUTICE USE: - TREATME NT OF ATTENTION - DEFICIT/HYP ERACIVITY DISORDER (ADHD R OPINIROLE TAB 4MG 100 NDC COD E:68462025801 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR MNBU0425312 001 EATMENT OF PARKINSONISM COMMERCIAL & CUSTOM INVOICE NO. F22352002653 DT. 18.09.20 22 F22352002660 DT. 19.09.202 2 S/BILL NO: 4270125 DT: 19 -SEP-22 S/BILL NO: 4284597 D T: 19-SEP-22 NET WT. 6,178.36 01 DATA LOGGERS SET TEMPERA MNBU0425312 001 TURE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

42 PALLETS 3378 CART ONS PHARMACEUTICALS AS UNDER TELMISARTAN TAB 80MG 30 ND C CODE:68462020130 HTS NO : 3 004.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERA PEUTICE USE : INDICATED FOR T MNBU0648358 001 HE TREATMENT OF HYPERTENSION , TO LOWER BLOOD PRESSURE TELMISARTAN TAB 80MG 30 NDC C ODE:68462020130 HTS NO : 3004 .90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEU TICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, T MNBU0648358 001 O LOWER BLOOD PRESSURE NAP ROXEN TAB 250MG 100 NDC CODE: 68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OX CARBAZEPINE TAB 300MG 100 NDC MNBU0648358 001 CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT ACAM PROSATE CALCIUM DR TAB 333MG 1 80 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 MNBU0648358 001 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE COMMERCIAL & CU STOM INVOICE NO. F22352002625 DT. 16.09.2022 F22352002621 DT. 15.09.2022 S/BILL NO:4229 649 DT 16-SEP-2022 S/BILL NO: MNBU0648358 001 4229703 DT 16-SEP-2022 NET W T. 9,446.33 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

15 PALLETS 342 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP CREAM 0.05% 60GM N DC CODE:68462052965 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE MMAU1093316 001 : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES C LOTRI-BETAMETHASONE CREAM 1.0/ MMAU1093316 001 .05% NDC CODE:68462029855 FD A PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 202894 THERAPEUT ICE USE: - TREATMENT A VARIET Y OF INFLAMED FUNGAL SKIN IN FECTIONS COMMERCIAL & CUSTO M INVOICE NO. F22335002505 DT MMAU1093316 001 . 06.09.2022 F22335002539 DT. 08.09.2022 S/BILL NO: 406013 3 DT:08/09/2022 S/BILL NO: 40 61128 DT:08/09/2022 NET WT: 1,300.32 KGS 15 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND MMAU1093316 001 (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND.

22 PALLETS 547 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP CREAM 0.05% 30GM NDC CODE:68462052935 FDA PROD UCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 209095 THERAPEUTICE US MNBU3207778 001 E: - CLOBETASOL PROPIONATE C REAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FORMULATIONS I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES CLOTRI-BETAMETHASONE CREAM 1.0 MNBU3207778 001 /.05% NDC CODE:68462029855 F DA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 202894 THERAPEU TICE USE: - TREATMENT A VARIE TY OF INFLAMED FUNGAL SKIN I NFECTIONS CLOBETASOL PROP C REAM 0.05% 15GM NDC CODE:6846 MNBU3207778 001 2052917 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 209095 CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTENCY CORT ICOSTEROID FORMULATIONS INDIC ATED FOR THE RELIEF OF THE I NFLAMMATORY AND PRURITIC MANI MNBU3207778 001 FESTATIONS OF CORTICOSTEROID- RESPONSIVE DERMATOSES CLOT RI-BETAMETHASONE CREAM 1.0/.05 % 15GM NDC CODE:68462029817 FDA PRODUCT CODE NO.:61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.:202894 THERAPEUT ICE USE: - TREATMENT A VARIET MNBU3207778 001 Y OF INFLAMED FUNGAL SKIN IN FECTIONS CLOBETASOL PROP CR EAM 0.05% 15GM NDC CODE:68462 052917 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 209095 CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTENCY CORTI MNBU3207778 001 COSTEROID FORMULATIONS INDICA TED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOSES CLOBE TASOL PROP CREAM 0.05% 45GM N DC CODE:68462052947 FDA PRODU CT CODE NO.: 64 L C J 67 H. MNBU3207778 001 T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO MNBU3207778 001 ID-RESPONSIVE DERMATOSES C OMMERCIAL & CUSTOM INVOICE NO. F22335002444 DT. 31.08.2022 F22335002449 DT. 31.08.2022 F22335002453 DT. 31.08.2022 S /BILL NO:3949781 DT:03/09/2022 S/BILL NO: 3958918 DT:04/09 /2022 S/BILL NO: 3958921 DT: MNBU3207778 001 04/09/2022 NET WT. 1,784.16 24 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND

1 PALLETS 14 CARTONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 15G M NDC CODE:68462053017 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE MNBU3422678 001 USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE S/BILL NO: 3866268 D T: 31/08/2022 COMMERCIAL & CU STOM INVOICE NO. F22335002347 DT. 29.08.2022 NET WT. 60.48 MNBU3422678 001 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND

28 PALLETS 721 CARTO NS PHARMACEUTICALS AS UNDER NYSTATIN-TRIAM 100K UNIT/0.1 % OINT 60GM NDC CODE:68462079 965 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 208300 TH MNBU3422678 001 ERAPEUTICE USE: - TREATMENT O F FUNGAL INFECTIONS OF THE SK IN, ESPECIALLY YEAST INFECTI ONS. NYSTATIN-TRIAM 100K UN IT/0.1% CREAM 15 GM NDC CODE: 68462031417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO. : 3004.40.0050 ANDA NO.: 208 MNBU3422678 001 136 THERAPEUTICE USE: - TREA TMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. BETAMETHASONE D IP AUG CREAM 0.05% 50GM NDC C ODE:68462029052 FDA PRODUCT C ODE NO.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO. MNBU3422678 001 :78-930 THERAPEUTICE USE: DE RMALOGIC USE MOMETASONE FUR O SOLN 0.1% 60ML NDC CODE:684 62038502 FDA PRODUCT CODE NO. : 62 F C L 53 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASON E FUROATE TOPICAL SOLUTION (L MNBU3422678 001 OTION) IS A CORTICOSTEROID I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE. MOMETASONE FURO SOLN 0.1% 30 ML NDC CODE:68462038537 FDA MNBU3422678 001 PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOP ICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS MNBU3422678 001 OF CORTICOSTEROID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE. CLOBETASOL P ROP SOLN 0.05% 50ML NDC CODE: 68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 0190 THERAPEUTICE USE: - GLU MNBU3422678 001 COCORTICOID / HUMAN - RX/SING LE INGREDIENT / NONSTERILE LI QUID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) NYSTATIN- TRIAM 100K UNIT/0.1% CREAM ND C CODE:68462031435 FDA PRODUC T CODE NO.: 64 L D J 61 H. T . S NO.: 3004.40.0050 ANDA N MNBU3422678 001 O.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECT IONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS S/BILL NO : 3860776 DT:30/08/2022 S/BI LL NO: 3778572 DT:27/08/2022 S/BILL NO: 3862973 DT:30/08/ 2022 COMMERCIAL & CUSTOM IN MNBU3422678 001 VOICE NO. F22335002345 DT. 29 .08.2022 F22335002302 DT. 26. 08.2022 F22335002346 DT. 29.0 8.2022 NET WT. 3,013.82 29 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: MNBU3422678 001 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

33 PALLETS 747 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLN 0.05% 5 0ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTI TLLU1205001 001 CE USE: - GLUCOCORTICOID / HU MAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETAS OL PROPIONATE (GLUCOCORTICOID ) CLOBETASOL PROP SOLN 0.05 % 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92 TLLU1205001 001 .45 ANDA NO.: 210190 THERAPE UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBE TASOL PROPIONATE (GLUCOCORTIC OID) FLUOCINONIDE CREAM 0.1 % 30GM NDC CODE:68462050535 FDA PRODUCT CODE NO.: 64 L C TLLU1205001 001 L 28 H. T. S NO.: 3004.32.00 .00 ANDA NO.: 91-282 THERAPE UTICE USE: - INDICATED FOR TH E RELIEF OF VARIOUS INFLAMMAT ORY AND PRURITIC MANIFESTATIO NS OF CORTICOSTEROID RESPONSI VE DERMATOSES IN PATIENTS. FLUOCINONIDE CREAM 0.1% 120G TLLU1205001 001 M NDC CODE:68462050566 FDA P RODUCT CODE NO.: 64 L C L 28 H. T. S NO.: 3004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE REL IEF OF VARIOUS INFLAMMATORY A ND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE D TLLU1205001 001 ERMATOSES IN PATIENTS. FLU OCINONIDE CREAM 0.1% 60GM NDC CODE:68462050565 FDA PRODUCT CODE NO.: 64 L C L 28 H. T. S NO.: 3004.32.00.00 ANDA N O.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE RELIEF OF VARIOUS INFLAMMATORY AND PR TLLU1205001 001 URITIC MANIFESTATIONS OF CORT ICOSTEROID RESPONSIVE DERMATO SES IN PATIENTS. S/BILL NO : 3607149 DT: 20/08/2022 S/B ILL NO: 3724324 DT: 25/08/2 022 S/BILL NO: 3724338 DT: 25/08/2022 COMMERCIAL & C USTOM INVOICE NO. F2233500214 TLLU1205001 001 6 DT. 18.08.2022 F22335002223 DT. 22.08.2022 F22335002224 DT. 22.08.2022 NET WT. 3,194. 88 17 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 TLLU1205001 001 30 USA

1 PALLETS 18 CARTONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 15G M NDC CODE:68462053017 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE MNBU0526241 001 USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE S/BILL NO: 3433930 D T:10-AUG-22 COMMERCIAL & CU STOM INVOICE NO. F22335002032 DT. 10.08.2022 NET WT. 77.76 MNBU0526241 001 02 DATA LOGGERS S/BILL NO: 3433930 DT:10-AUG-22 NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND

14 PALLETS 345 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP CREAM 0.05% 15GM NDC CODE:68462052917 FDA PROD UCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 209095 CLOBETASOL PROP MNBU3552368 001 IONATE CREAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FORMU LATIONS INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND P RURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOSES CLOBETASOL PROP OINT 0.05% 60GM NDC CODE:684620530 MNBU3552368 001 65 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 208933 THE RAPEUTICE USE: - INDICATED FO R THE RELIEF OF THE INFLAMMAT ORY AND PRURITIC MANIFESTATIO NS OF CORTICOSTEROID-RESPONSI VE DERMATOESE CLOBETASOL P MNBU3552368 001 ROP OINT 0.05% 60GM NDC CODE: 68462053065 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO. : 3004.90.92.45 ANDA NO.: 20 8933 THERAPEUTICE USE: - IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID MNBU3552368 001 -RESPONSIVE DERMATOESE C OMMERCIAL & CUSTOM INVOICE NO. F22335001930 DT. 31.07.2022 F22335001986 DT. 06.08.2022 NET WT. 1,028.16 06 DATA LO GGERS HUMIDITY:65% NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NU MNBU3552368 001 MA-DROZ 2 NEUCHATEL - 2000 S WITZERLAND

14 PALLETS 240 CARTONS PH ARMACEUTICALS AS UNDER ALCL OMETASONE DIP OINT 0.05% 45GM NDC CODE:68462029947 FDA PRO DUCT CODE NO.: 62 B C J 10 H . T. S NO.: 3004.49.00.50 AN DA NO.: 79-227 THERAPEUTICE U MNBU3552368 001 SE: INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRUR ITIC MANIFESTATIONS OF CORTIC OSTEROID-RESPONSIVE DERMATOSE S. ALCLOMETASONE DIP OINT 0 .05% 60GM NDC CODE:6846202996 5 FDA PRODUCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49 MNBU3552368 001 .00.50 ANDA NO.: 79-227 THER APEUTICE USE: INDICATED FOR T HE RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOSES. CLOBETASOL PRO P SOLN 0.05% 25ML NDC CODE:68 462053228 FDA PRODUCT CODE NO MNBU3552368 001 .: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2101 90 THERAPEUTICE USE: - GLUCO CORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQU ID / CLOBETASOL PROPIONATE ( GLUCOCORTICOID) COMMERCIA L & CUSTOM INVOICE NO. F22335 MNBU3552368 001 001906 DT. 31.07.2022 F223350 01985 DT. 06.08.2022 NET WT. 976.75 12 DATA LOGGERS HUM IDITY:65% NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

5 PALLETS 107 CARTONS PHA RMACEUTICALS AS UNDER CLO BETASOL PROP CREAM 0.05% 60GM NDC CODE:68462052965 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 209095 THERAPE MNBU3572087 001 UTICE USE: - CLOBETASOL PROP IONATE CREAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FO RMULATIONS INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOSES CLOBETASOL MNBU3572087 001 PROP CREAM 0.05% 45GM NDC CO DE:68462052947 FDA PRODUCT C ODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE US E: - CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTEN CY CORTICOSTEROID FORMULATIO MNBU3572087 001 NS INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRUR ITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMA TOSES CLOBETASOL PROP CRE AM 0.05% 60GM NDC CODE:68462 052965 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: MNBU3572087 001 3004.90.92.45 ANDA NO.: 20 9095 THERAPEUTICE USE: - C LOBETASOL PROPIONATE CREAM I S A SUPER-HIGH POTENCY CORTI COSTEROID FORMULATIONS INDIC ATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTER MNBU3572087 001 OID-RESPONSIVE DERMATOSES COMMERCIAL & CUSTOM INVOICE NO. F22335001715 DT. 22.07. 2022 F22335001761 DT. 25.07. 2022 NET WT. 245.52 KGS 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 D MNBU3572087 001 EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND

28 PALLETS 723 CARTONS PH ARMACEUTICALS AS UNDER CL OBETASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA P RODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 210190 THERAPE MNBU3572087 001 UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIE NT / NONSTERILE LIQUID / C LOBETASOL PROPIONATE (GLUCOC ORTICOID) MOMETASONE FURO CREAM 0.1% 45GM NDC CODE:68 462019255 FDA PRODUCT CODE N O.: 62 F C J 53 H. T. S NO MNBU3572087 001 .: 3004.40.49.50 ANDA NO.: 78-541 THERAPEUTICE USE: A NTI-INFLAMMATORY- DERMATOLOG IC MOMETASONE FURO SOLN 0 .1% 30ML NDC CODE:6846203853 7 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 MNBU3572087 001 THERAPEUTICE USE: MOMETASON E FUROATE TOPICAL SOLUTION ( LOTION) IS A CORTICOSTEROI D INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORT ICOSTEROID-RESPONSIVE DERMAT OSES IN PATIENTS #12 YEARS MNBU3572087 001 OF AGE. MOMETASONE FURO CREAM 0.1% 15GM NDC CODE:684 62019217 FDA PRODUCT CODE NO .: 62 F C J 53 H. T. S NO. : 3004.40.49.50 ANDA NO.:7 8-541 THERAPEUTICE USE: AN TI-INFLAMMATORY- DERMATOLOGI C MOMETASONE FURO SOLN 0. MNBU3572087 001 1% 60ML NDC CODE:68462038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004 .90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (L OTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF MNBU3572087 001 THE INFLAMMATORY AND PRURIT IC MANIFESTATIONS OF CORTI COSTEROID-RESPONSIVE DERMATO SES IN PATIENTS #12 YEARS OF AGE. COMMERCIAL & CUST OM INVOICE NO. F22335001760 DT. 25.07.2022 F22335001714 DT. 22.07.2022 NET WT. 2,531 MNBU3572087 001 .90 KGS 28 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

36 PALLETS 3330 CARTONS P HARMACEUTICALS AS UNDER EZETI MIBE TAB 10MG 30 NDC CODE:684 62022630 FDA PRODUCT CODE NO. : 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #0785 60 THERAPEUTICE USE: LIPID L MNBU0638998 001 OWERING AGENT EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49. 00.10 ANDA NO.: #078560 THER APEUTICE USE: LIPID LOWERING AGENT PRAVASTATIN SOD TAB 2 0MG 500 NDC CODE:68462019605 MNBU0638998 001 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:-77-987 THERAP EUTICE USE:-HYPOLIPDAEMIC RANOLAZINE ER TAB 500MG 60 ND C CODE:68462031960 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA MNBU0638998 001 NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC MNBU0638998 001 Y) ATTACK OF ANGINA FENOFI BRATE CAP 200MG 100 NDC CODE: 68462058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD MNBU0638998 001 L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA N APROXEN SOD TAB 550MG 100 NDC CODE:68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N MNBU0638998 001 O.:-78-314 THERAPEUTICE USE:- ANTI INFLAMMATORY, ANALGESIC CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT MNBU0638998 001 AGONIST COMMERCIAL & CUSTOM INVOICE NO. F22387000549 DT. 14.07.2022 S/BILL NO.4010158 DT.15.07.2022 NET WT. 3,271. 628 KGS DATA LOGGERS SET TEM PERATURE : +18 DEGREES

10 PALLETS 339 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP OINT 0.05% 60GM N DC CODE:68462053065 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE MNBU3989208 001 : - INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRUR ITIC MANIFESTATIONS OF CORTIC OSTEROID-RESPONSIVE DERMATOES E ATOVAQUONE OS 750MG/5ML 4 2X5ML NDC CODE:68462042169 COMMERCIAL & CUSTOM INVOICE N O. F22335001490 DT. 08.07.202 MNBU3989208 001 2 F22335001507 DT. 09.07.2022 NET WT. 1,005.120 KGS 10 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR MNBU3989208 001 OZ 2 NEUCHATEL - 2000 SWITZE RLAND

23 PALLETS 503 CARTONS PHARMACEUTICALS AS UNDER MO METASONE FURO SOLN 0.1% 30ML NDC CODE:68462038537 FDA PROD UCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 AND A NO.:090506 THERAPEUTICE USE SUDU6104070 001 : MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. MOMETASONE FURO SUDU6104070 001 OINT 0.1% 15GM NDC CODE:68462 022517 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 30 04.40.49.50 ANDA NO.:78-571 THERAPEUTICE USE: ANTI-INFLAM MATORY- DERMATOLOGIC MOMET ASONE FURO CREAM 0.1% 45GM ND C CODE:68462019255 FDA PRODUC SUDU6104070 001 T CODE NO.: 62 F C J 53 H. T . S NO.: 3004.40.49.50 ANDA NO.:78-541 THERAPEUTICE USE: ANTI-INFLAMMATORY- DERMATOLO GIC MOMETASONE FURO SOLN 0. 1% 60ML NDC CODE:68462038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.9 SUDU6104070 001 2.45 ANDA NO.:090506 THERAPE UTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAM MATORY AND PRURITIC MANIFESTA TIONS OF CORTICOSTEROID-RESPO NSIVE DERMATOSES IN PATIENTS SUDU6104070 001 #12 YEARS OF AGE. MOMETAS ONE FURO CREAM 0.1% 15GM NDC CODE:68462019217 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO .:78-541 THERAPEUTICE USE: A NTI-INFLAMMATORY- DERMATOLOGI C MOMETASONE FURO CREAM 0.1 SUDU6104070 001 % 45GM NDC CODE:68462019255 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49 .50 ANDA NO.:78-541 THERAPEU TICE USE: ANTI-INFLAMMATORY- DERMATOLOGIC BETAMETHASONE DIP AUG CREAM 0.05% 50GM NDC CODE:68462029052 FDA PRODUCT SUDU6104070 001 CODE NO.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA N O.:78-930 THERAPEUTICE USE: DERMALOGIC USE MOMETASONE F URO SOLN 0.1% 60ML NDC CODE:6 8462038502 FDA PRODUCT CODE N O.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 ANDA NO.:0905 SUDU6104070 001 06 THERAPEUTICE USE: MOMETAS ONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOST EROID-RESPONSIVE DERMATOSES I N PATIENTS #12 YEARS OF AGE. SUDU6104070 001 BETAMETHASONE DIP AUG CREA M 0.05% 15GM NDC CODE:6846202 9017 FDA PRODUCT CODE NO.: 6 4 L C J 06 H. T. S NO.: 3004 .90.92.45 ANDA NO.:78-930 TH ERAPEUTICE USE: DERMALOGIC US E COMMERCIAL & CUSTOM INVOI CE NO. F22335001353 DT. 30.06 SUDU6104070 001 .2022 F22335001354 DT. 30.06. 2022 F22335001355 DT. 30.06.2 022 F22335001418 DT. 30.06.20 22 F22335001423 DT. 01.07.202 2 S/BILL NO: 2609130 DT:05/0 7/2022 S/BILL NO: 2609183 DT : 05/07/2022 S/BILL NO: 2614 137 DT: 05/07/2022 S/BILL NO: SUDU6104070 001 2593086 DT: 04/07/2022 S/BI LL NO: 2593082 DT: 04/07/2022 NET WT: 1,642.75 KGS 30 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC SUDU6104070 001 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

50 PALLETS 2797 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0656482 001 INFLAMMATORY, ANALGESIC CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST ROPINIROLE TAB 0.25MG 10 MNBU0656482 001 0 NDC CODE:68462025301 FDA P RODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTIC E USE:-TREATMENT OF PARKINSO NISM TOPIRAMATE TAB 25MG 50 0 NDC CODE:68462010805 FDA P RODUCT CODE NO.: 61 M C A 40 MNBU0656482 001 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT ZONISA MIDE CAP 25MG 100 NDC CODE:68 462012801 FDA PRODUCT CODE N O.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-6 51 THERAPEUTICE USE:-ANTISEI MNBU0656482 001 ZURE DRUG ACAMPROSATE CALCI UM DR TAB 333MG 180 NDC CODE: 68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO. : 3004.90.92.40 ANDA NO.:202 229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE MUPIROCIN OINT 2% 22GM NDC MNBU0656482 001 CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO .: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F223520 01037 DT. 12.06.2022 F2235200 1038 DT. 12.06.2022 F22352001 MNBU0656482 001 039 DT. 12.06.2022 S/BILL NO: 2092449 DT 13-JUN-2022 S/BIL L NO: 2092455 DT 13-JUN-2022 S/BILL NO: 2092461 DT 13-JUN-2 022 NET WT. 9,236.64 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE MNBU0656482 001 S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

18 PALLETS 527 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 3 0GM NDC CODE:68462053035 FDA PRODUCT CODE NO.: 64 L C J 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTI MNBU3092046 001 CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DER MATOESE CLOBETASOL PROP OIN T 0.05% 60GM NDC CODE:6846205 3065 FDA PRODUCT CODE NO.: 6 4 L C J 67 H. T. S NO.: 3004 MNBU3092046 001 .90.92.45 ANDA NO.: 208933 T HERAPEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMM ATORY AND PRURITIC MANIFESTAT IONS OF CORTICOSTEROID-RESPON SIVE DERMATOESE CLOBETASOL PROP OINT 0.05% 15GM NDC COD E:68462053017 FDA PRODUCT COD MNBU3092046 001 E NO.: 64 L C J 67 H. T. S N O.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOESE C OMMERCIAL & CUSTOM INVOICE NO. MNBU3092046 001 F22335001050 DT. 11.06.2022 F22335001051 DT. 11.06.2022 NET WT. 1,370.88 KGS 18 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL - 2000 SWITZE MNBU3092046 001 RLAND S/BILL NO: 2109632 D T:14/06/2022 S/BILL NO: 2111 571 DT:14/06/2022

PHARMACEUTICALS AS UNDER FL UOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210539 SYNTHET IC CORTICOSTEROID FOR TOPICAL MNBU0391228 001 DERMATOLOGIC USE FOR THE TRE ATMENT OF PSORIASIS OF THE SC ALP NYSTATIN-TRIAM 100K UNI T/0.1% OINT 30GM NDC CODE:684 62079935 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREATM MNBU0391228 001 ENT OF FUNGAL INFECTIONS OF T HE SKIN, ESPECIALLY YEAST IN FECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:6 8462029017 FDA PRODUCT CODE N O.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-9 30 THERAPEUTICE USE: DERMALO MNBU0391228 001 GIC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND MNBU0391228 001 ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. 13 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR MNBU0391228 001 EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

PHARMACEUTICALS AS UNDER FL UOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210539 SYNTHET IC CORTICOSTEROID FOR TOPICAL MNBU0391228 001 DERMATOLOGIC USE FOR THE TRE ATMENT OF PSORIASIS OF THE SC ALP NYSTATIN-TRIAM 100K UNI T/0.1% OINT 30GM NDC CODE:684 62079935 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREATM MNBU0391228 001 ENT OF FUNGAL INFECTIONS OF T HE SKIN, ESPECIALLY YEAST IN FECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:6 8462029017 FDA PRODUCT CODE N O.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-9 30 THERAPEUTICE USE: DERMALO MNBU0391228 001 GIC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND MNBU0391228 001 ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. 13 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR MNBU0391228 001 EES TO +25 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA

24 PALLETS 464 CARTONS P HARMACEUTICALS AS UNDER CLO BETASOL PROP SOLUTION 0.05% 50 ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTIC MNBU3560532 001 E USE: - GLUCOCORTICOID / HUM AN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETASO L PROPIONATE (GLUCOCORTICOID) MOMETASONE FUROATE OINTMEN T 0.1% 15GM NDC CODE:68462022 517 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004. MNBU3560532 001 40.49.50 ANDA NO.:78-571 THE RAPEUTICE USE: ANTI-INFLAMMAT ORY- DERMATOLOGIC HYDROCOR TISONE VAL OINTMENT 0.2% 45GM NDC CODE:68462083647 FDA PRO DUCT CODE NO.: 64 L C L 71 H . T. S NO.: 3004.49.00.50 AN DA NO.: 211750 THERAPEUTICE U MNBU3560532 001 SE: - INDICATED FOR THE RELIE F OF THE INFLAMMATORY AND PR URITIC MANIFESTATIONS OF CORT ICOSTEROID RESPONSIVE DERMATO SES IN ADULT PATIENTS. CLO BETASOL PROP SOLUTION 0.05% 50 ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 MNBU3560532 001 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTIC E USE: - GLUCOCORTICOID / HUM AN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETASO L PROPIONATE (GLUCOCORTICOID) NYSTATIN-TRIAM 100K UNIT /0.1% CREAM 30GM NDC CODE:684 MNBU3560532 001 62031435 FDA PRODUCT CODE NO. : 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS F22335000546 DT. 12 .05.2022 F22335000561 DT. 12. MNBU3560532 001 05.2022 F22335000567 DT. 13.0 5.2022 F22335000568 DT. 13.05 .2022 S/BILL NO: 1426871 DT:1 7/05/2022 S/BILL NO: 1426894 DT:17/05/2022 S/BILL NO: 1439 035 DT:17/05/2022 S/BILL NO: 1439015 DT:17/05/2022 NET WT: 2,290.08 KGS 28 DATA LOGGE MNBU3560532 001 RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA

5 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER AZELAI C ACID GEL 15% 50GM NDC CODE: 68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO. : 3004.49.00.50 ANDA NO.: 20 4637 INDICATED FOR TOPICAL T MNBU0373060 001 REATMENT OF THE INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA COMMER CIAL & CUSTOM INVOICE NO. F22 352000558 DT. 13.05.2022 S/BI LL NO: 1396988 DT 14-MAY-2022 NET WT: 978.990 KGS 05 DATA LOGGERS SET TEMPERATURE : MNBU0373060 001 +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND

11 PALLETS 192 CARTONS PHARMACEUTICALS AS UNDER HYDR OCORTISONE VAL OINTMENT 0.2% 1 5GM NDC CODE:68462083617 FDA PRODUCT CODE NO.: 64 L C L 7 1 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211750 THERAPEUTI MNBU3422908 001 CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS. CLOBETASOL PROP SOLUTION 0.05 % 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C MNBU3422908 001 L 67 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 210190 THERAPE UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBE TASOL PROPIONATE (GLUCOCORTIC OID) TRIAMCINOLONE ACE OINT 0.5% 15GM NDC CODE:684620798 MNBU3422908 001 17 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49 .00.50 ANDA NO.:206379 THERA PEUTICE USE: - REDUCES THE SW ELLING, ITCHING, AND REDNESS OF SKIN COMMERCIAL & CUSTO M INVOICE NO. F22335000265 DT . 25.04.2022 NET WT. 868.80 K MNBU3422908 001 GS 11 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 9968246 D T: 26/04/2022

18 PALLETS 457 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP OINTMENT 0.05% 60G M NDC CODE:68462053065 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE MNBU3537234 001 USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE CLOBETASOL PROP OINTM ENT 0.05% 30GM NDC CODE:68462 053035 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 30 MNBU3537234 001 04.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATE D FOR THE RELIEF OF THE INFLA MMATORY AND PRURITIC MANIFEST ATIONS OF CORTICOSTEROID-RESP ONSIVE DERMATOESE CLOBETAS OL PROP CREAM 0.05% 30GM NDC CODE:68462052935 FDA PRODUCT MNBU3537234 001 CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO .: 209095 THERAPEUTICE USE: - CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTENCY CORT ICOSTEROID FORMULATIONS INDIC ATED FOR THE RELIEF OF THE I NFLAMMATORY AND PRURITIC MANI MNBU3537234 001 FESTATIONS OF CORTICOSTEROID- RESPONSIVE DERMATOSES CLOB ETASOL PROP CREAM 0.05% 60GM NDC CODE:68462052965 FDA PROD UCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 209095 THERAPEUTICE US E: - CLOBETASOL PROPIONATE C MNBU3537234 001 REAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FORMULATIONS I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES CLOBETASOL PROP OINTMENT 0.05% 45GM NDC CODE:68462053047 F MNBU3537234 001 DA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 208933 THERAPEU TICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATORY A ND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE D ERMATOESE CLOBETASOL PROP O MNBU3537234 001 INTMENT 0.05% 30GM NDC CODE:6 8462053035 FDA PRODUCT CODE N O.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208 933 THERAPEUTICE USE: - INDI CATED FOR THE RELIEF OF THE I NFLAMMATORY AND PRURITIC MANI FESTATIONS OF CORTICOSTEROID- MNBU3537234 001 RESPONSIVE DERMATOESE CLOB ETASOL PROP OINTMENT 0.05% 15G M NDC CODE:68462053017 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND MNBU3537234 001 PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE CLOBETASOL PROP OINTM ENT 0.05% 60GM NDC CODE:68462 053065 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATE MNBU3537234 001 D FOR THE RELIEF OF THE INFLA MMATORY AND PRURITIC MANIFEST ATIONS OF CORTICOSTEROID-RESP ONSIVE DERMATOESE COMMERCI AL & CUSTOM INVOICE NO. F2233 5000102 DT. 12.04.2022 F22335 000103 DT. 12.04.2022 F223350 00114 DT. 13.04.2022 F2233500 MNBU3537234 001 0115 DT. 13.04.2022 F22335000 116 DT. 13.04.2022 NET WT: 1 ,148.40 KGS 18 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE MNBU3537234 001 NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND

8 PALLETS 164 CARTONS PHARMA CEUTICALS AS UNDER AZELAIC AC ID GEL 15% 50GM NDC CODE:6846 2062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREAT MNBU9170090 001 MENT OF THE INFLAMMATORY PAPU LES AND PUSTULES OF MILD TO MODERATE ROSACEA COMMERCIAL & CUSTOM INVOICE NO. F223520 00248 DT. 22.04.2022 S/BILL N O: 9911921 DT 23-APR-2022 NET WT: 1660.26 KGS 08 DATA LOG GERS NOTIFY PARTY:2 GLENMA MNBU9170090 001 RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND AGENT ADDRESS AT DESTINATION MAERSK CHARLOTTE CUSTOMER RES OURCE CENTER 9300 ARROWPOINT BLVD CHARLOTTE NC USA 28273 TEL: +1 (800) 321 8807

10 PALLETS 156 CART ONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINTMENT 0. 05% 45GM NDC CODE:68462053047 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208933 THERA TEMU9758785 001 PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOESE CLOBETASOL PRO P OINTMENT 0.05% 30GM NDC COD E:68462053035 FDA PRODUCT COD E NO.: 64 L C J 67 H. T. S N TEMU9758785 001 O.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOESE C LOBETASOL PROP OINTMENT 0.05% 60GM NDC CODE:68462053065 FD TEMU9758785 001 A PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 208933 THERAPEUT ICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOESE CLOBETASOL PROP OI TEMU9758785 001 NTMENT 0.05% 45GM NDC CODE:68 462053047 FDA PRODUCT CODE NO .: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2089 33 THERAPEUTICE USE: - INDIC ATED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R TEMU9758785 001 ESPONSIVE DERMATOESE CLOBE TASOL PROP OINTMENT 0.05% 15GM NDC CODE:68462053017 FDA PR ODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 A NDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE RELI EF OF THE INFLAMMATORY AND P TEMU9758785 001 RURITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMAT OESE CLOTRIM-BETAMETHASONE CRM 1.0/.05% 45GM NDC CODE:68 462029855 FDA PRODUCT CODE NO .: 61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2028 94 THERAPEUTICE USE: - TREAT TEMU9758785 001 MENT A VARIETY OF INFLAMED FU NGAL SKIN INFECTIONS COMME RCIAL & CUSTOM INVOICE NO. F2 2335000060 DT. 08.04.2022 F22 335000061 DT. 08.04.2022 F223 35000087 DT. 11.04.2022 F2233 5000088 DT. 11.04.2022 S/BILL NO: 9604214 DT:11.04.2022 TEMU9758785 001 S/BILL NO: 9604161 DT:11.04.2 022 S/BILL NO: 9660016 DT:12. 04.2022 S/BILL NO: 9660019 DT :12.04.2022 NET WT. 640.80 KGS 10 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 TEMU9758785 001 SWITZERLAND

LOCAL ANTISEPTIC AND ANTI INFLAMMATORY 210PKG ELECTRICAL PANELS 3PKG MEDICAL DEVICE 2PKG PLASTIC TUBE ASSEMBLY 2PKG HOUSEHOLD GOODS AND USED KOSU4955742 001 PERSONAL EFFECTS 2PKG GALVANIZED IRON RULER 3PKG VEHICLE CHASSIS 1PKG SPARE PARTS FOR MTU ENGINES 2PKG HBL SJOCAL00120 KOSU4955742 001 SJOHAI00657 SJOHOU00066 SJOSYD00236 SJOPHX00102 SJOMIA02687 SJOHOU00065 SJOMIA02690

13 PALLETS 285 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE EAR DROPS 0.01% 2 0ML NDC CODE:68462018556 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211815 FOR THE TR MNBU3283551 001 EATMENT OF CHRONIC ECZEMATOUS EXTERNAL OTITIS ALCLOMETA SONE DIP OINTMENT 0.05% 15GM NDC CODE:68462029917 FDA PROD UCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 AND A NO.: 79-227 THERAPEUTICE US E: INDICATED FOR THE RELIEF O MNBU3283551 001 F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOSES . CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE:684620532 53 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 210190 THE MNBU3283551 001 RAPEUTICE USE: - GLUCOCORTICO ID / HUMAN - RX/SINGLE INGRED IENT / NONSTERILE LIQUID / C LOBETASOL PROPIONATE (GLUCOCO RTICOID) HYDROCORTISONE VAL OINTMENT 0.2% 45GM NDC CODE: 68462083647 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO. MNBU3283551 001 : 3004.49.00.50 ANDA NO.: 21 1750 THERAPEUTICE USE: - IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN ADU LT PATIENTS. ALCLOMETASONE DIP OINTMENT 0.05% 45GM NDC MNBU3283551 001 CODE:68462029947 FDA PRODUCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 ANDA NO .: 79-227 THERAPEUTICE USE: INDICATED FOR THE RELIEF OF T HE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES. MNBU3283551 001 COMMERCIAL & CUSTOM INVOICE N O. F22235005479 DT. 31.03.202 2 F22235005480 DT. 31.03.2022 S/BILL NO:9517897 DT:06/04/2 022 S/BILL NO: 9519966 DT:06/ 04/2022 NET WT: 853.97 KGS 13 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY MNBU3283551 001 PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

46 PALLETS 3138 CARTONS P HARMACEUTICALS AS UNDER VER APAMIL HCL ER TABS 180MG 100S NDC CODE:68462029301 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U MNBU4164665 001 SE: - ANGINA PRAMIPEXOLE T ABS 0.5MG 90'S NDC CODE:68462 033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 30 04.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PA RKINSON#S DISEASE OMEPRAZOL E DR CAPSULES 40MG 30'S NDC C MNBU4164665 001 ODE:68462039730 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE NAPROXEN TABLETS 500MG 500'S NDC CODE: 68462019005 FDA PRODUCT CODE MNBU4164665 001 NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 1000 'S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA MNBU4164665 001 NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE TO PIRAMATE TABLETS 100MG 60'S N DC CODE:68462010960 FDA PRODU CT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE U MNBU4164665 001 SE:-ANTICONVULSANT COMMERCI AL & CUSTOM INVOICE NO. F2235 2000037 DT. 06.04.2022 F22352 000038 DT. 06.04.2022 NET WT: 10,616.74 KGS 02 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D MNBU4164665 001 EGREES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

20 PALLETS 766 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE BODY OIL 0.01% 11 8ML NDC CODE:68462059189 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210556 SYNTHETIC MNBU3590603 001 CORTICOSTEROID FOR TOPICAL DE RMATOLOGIC USE FOR THE TREATM ENT OF PSORIASIS OF THE SCALP CLOBETASOL PROP SOLUTION 0 .05% 25ML NDC CODE:6846205322 8 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 210190 THER MNBU3590603 001 APEUTICE USE: - GLUCOCORTICOI D / HUMAN - RX/SINGLE INGREDI ENT / NONSTERILE LIQUID / CL OBETASOL PROPIONATE (GLUCOCOR TICOID) FLUOCINOLONE ACE SC ALP OIL 0.01% 118ML NDC CODE: 68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO. MNBU3590603 001 : 3004.49.00.50 ANDA NO.: 21 0539 SYNTHETIC CORTICOSTEROID FOR TOPICAL DERMATOLOGIC US E FOR THE TREATMENT OF PSORIA SIS OF THE SCALP NYSTATIN-T RIAM 100K UNIT/0.1% OINT 30GM NDC CODE:68462079935 FDA PRO DUCT CODE NO.: 64 L D J 60 H MNBU3590603 001 . T. S NO.: 3004.49.00.50 AN DA NO.: 208300 THERAPEUTICE U SE: - TREATMENT OF FUNGAL IN FECTIONS OF THE SKIN, ESPECIA LLY YEAST INFECTIONS. HYDR OCORTISONE VAL OINTMENT 0.2% 6 0GM NDC CODE:68462083665 FDA PRODUCT CODE NO.: 64 L C L 7 MNBU3590603 001 1 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211750 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS. COMMERCIAL & CUSTOM INVOICE N MNBU3590603 001 O. F22235005451 DT. 31.03.202 2 S/BILL NO: 9498224 DT:05/04 /2022 NET WT: 1,805.28 KGS 20 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U MNBU3590603 001 SA